NAGE:NASDAQ, Niagen Bioscience, Inc.

NAGE stock overview

Niagen Bioscience, Inc. (NAGE:NASDAQ) closed at $2.43 on October 23, 2026, down 3.57% on the day. The stock trades 69.4% below its 52-week high of $7.95 and 0.4% above its 52-week low of $2.42. Over the past year, it lost 67.9%. Niagen Bioscience, Inc. is part of the Health Care sector.

Key figures

Price
$2.43
Day change
-3.57%
Volume
543,768
Average volume
547,750
Market cap
192M+
52-week range
$2.42 – $7.95
50-day average
$2.92
200-day average
$4.02

Price action over the past year

In 252 trading sessions since October 23, 2025, NAGE closed higher on 113 days (45%). Its best day was October 31, 2025 (+6.05%) and its worst was May 7, 2026 (-15.69%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

NAGE news

About Niagen Bioscience, Inc.

ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors.

Similar stocks

Find more stocks like NAGE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.